1. Home
  2. LASR vs DNLI Comparison

LASR vs DNLI Comparison

Compare LASR & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo nLIGHT Inc.

LASR

nLIGHT Inc.

HOLD

Current Price

$48.08

Market Cap

4.1B

Sector

Technology

ML Signal

HOLD

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$25.60

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LASR
DNLI
Founded
2000
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.7B
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
LASR
DNLI
Price
$48.08
$25.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
14
Target Price
$54.31
$34.33
AVG Volume (30 Days)
1.3M
1.4M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
62.99
N/A
EPS
N/A
N/A
Revenue
$191,359,000.00
N/A
Revenue This Year
$10.91
N/A
Revenue Next Year
$14.32
$408.85
P/E Ratio
N/A
N/A
Revenue Growth
38.09
N/A
52 Week Low
$25.74
$12.58
52 Week High
$86.95
$27.30

Technical Indicators

Market Signals
Indicator
LASR
DNLI
Relative Strength Index (RSI) 36.51 58.72
Support Level $42.06 $17.99
Resistance Level $48.31 $25.74
Average True Range (ATR) 4.82 0.84
MACD -1.60 0.03
Stochastic Oscillator 3.84 87.79

Price Performance

Historical Comparison
LASR
DNLI

About LASR nLIGHT Inc.

nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products segment, which includes semiconductor lasers, fiber lasers, and directed energy products; and Advanced Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA, of which maximum revenue is derived from North America.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: